MedTrace Logo

Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease

NCT04578678 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-04-13

No results posted yet for this study

Summary

The primary objective of the study is to determine if subthalamic nucleus (STN) deep brain stimulation (DBS) using the Vercise directional leads improves neuropsychiatric state and neuropsychiatric fluctuations 12 months after surgery in a large consecutive series of STN-DBS Parkinson's disease (PD) patients.

Conditions

Interventions

OTHER

Steering

Fine tuning of the STN-DBS settings

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Ines Debove, MD · Insel Gruppe AG, University Hospital Bern

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-09
Primary Completion
2025-01-31
Completion
2026-03-31

Countries

  • France
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04578678 on ClinicalTrials.gov